Table 3.
Comparision of clinical features and complications of our FCPD patients with patients reported from other centers
| Ref. | n | Country | Age (years) | Duration of diabetes (years) | HbA1C (%) | Retinopathy (%) | Nephropathy (%) | Neuropathy (%) | CAD± (%) | PVDδ (%) | Type of diabetes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Barman et al.[24] | 277 | India | 47±11 | 11±10 | 10.7±2.5 | 36.1 | 10.1 | 20.9 | 5.8 | 4.7 | FCPD* |
| Mittal et al.[25] | 80 | India | 33±11 | 4±5 | 8.1±3.1 | 15 | 26 | 19 | - | - | FCPD |
| Braini et al.[26] | 86 | Italy | 52±9.9 | 12.4±6.8 | 7.3±1.2 | 37 | 23.8 | - | - | - | CP** |
| Present study | 124 | India | 35±9.4 | 7.38±5 | 10.0±2.9 | 9 | 18.5 | 32 | 1.6 | - | FCPD |
±Coronary artery disease; δPeripheral vascular disease; *Fibrocalculous pancreatic diabetes; **Chronic pancreatitis